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Abstract. The a-factor receptor (Ste3p) is one of two 
pheromone receptors in the yeast Saccharomyces cere- 
visiae that enable the cell-cell communication of mat- 
ing. In this report, we show that this receptor is subject 
to two distinct covalent modifications--phosphoryla- 
tion and ubiquitination. Phosphorylation, evident on 
the unstimulated receptor, increases upon challenge by 
the receptor's ligand, a-factor. We suggest that this 
phosphorylation likely functions in the adaptive, nega- 
tive regulation of receptor activity. Removal of phos- 
phorylation by phosphatase treatment uncovered two 
phosphatase-resistant modifications identified as ubiq- 
uitination using a myc-epitope-tagged ubiquitin con- 
struct. Ste3p undergoes rapid, ligand-independent turn- 
over that depends on vacuolar proteases and also on 
transport of the receptor from surface to vacuole (i.e., 
endocytosis) (Davis, N.G., J.L. Horecka, and G.F. 
Sprague, Jr., 1993 J. Cell Biol. 122:53-65). An end4 mu- 
tation, isolated for its defect in the endocytic uptake of 
a-factor pheromone (Raths, S., J. Rohrer, F. Crausaz, 
and H. Riezman. 1993. J. Cell Biol. 120:55-65), blocks 
constitutive endocytosis of the a-factor receptor, yet 
fails to block ubiquitination of the receptor. In fact, 
both phosphorylation and ubiquitination of the surface- 
bound receptor were found to increase, suggesting that 
these modifications may occur normally while the re- 
ceptor is at the cell surface. In a mutant strain con- 
structed to allow for depletion of ubiquitin, the level of 
receptor ubiquitination was found to be substantially 
decreased. Correlated with this was an impairment of 
receptor degradative turnover--receptor half-life that 
is normally ~20 min at 30°C was increased to ~2 h un- 
der these ubiquitin-depletion conditions. Furthermore, 
surface residency, normally of short duration in wild- 
type cells (terminated by endocytosis to the vacuole), 
was found to be prolonged; the majority of the receptor 
protein remained surface localized fully 2 h after bio- 
synthesis. Thus, the rates of a-factor receptor endocyto- 
sis and consequent vacuolar turnover depend on the 
available level of ubiquitin in the cell. In cells mutant 
for two E2 activities, i.e., ubc4A ubc5A cells, the recep- 
tor was found to be substantially less ubiquitinated, and 
in addition, receptor turnover was slowed, suggesting 
that Ubc4p and Ubc5p may play a role in the recogni- 
tion of the receptor protein as substrate for the ubiq- 
uitin system. In addition to ligand-independent uptake, 
the a-factor receptor also undergoes a ligand-depen- 
dent form of endocytosis (Davis, N.G., J.L. Horecka, 
and G.F. Sprague, Jr. 1993. J. Cell. Biol. 122:53-65). 
Concurrent with ligand-dependent uptake, we now 
show that the receptor undergoes ligand-induced ubiq- 
uitination, suggesting that receptor ubiquitination may 
function in the ligand-dependent endocytosis of the 
a-factor receptor as well as in its constitutive endocyto- 
sis. To account for these findings, we propose a model 
wherein the covalent attachment of ubiquitin to surface 
receptor triggers endocytic uptake. 
T 
wo distinct systems effect cellular protein degrada- 
tion-the  lysosomal  system  and  the  ubiquitin- 
dependent proteasomal system. The two degrada- 
tion mechanisms  act upon different sets of substrates,  a 
consequence of their distinct subcellular compartmental- 
ization.  While lysosomal proteases are enclosed within the 
membrane-bound  confines of the  lysosome, the protea- 
some is available to digest both cytoplasmic and nuclear 
proteins. 
Lysosomal degradation  requires transport  of substrate 
proteins to the lysosome. This may be by endocytosis, a 
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process that retrieves substrates from the extracellular mi- 
lieu, as well as surface-resident membrane proteins. Under 
conditions of cellular stress (e.g., starvation), the process 
of autophagy also can deliver bulk cytoplasmic proteins to 
the lysosome for degradation (Seglen and Bohley, 1992). 
The selection of substrates for proteasomal degradation 
involves the covalent addition of the protein ubiquitin to 
substrate  proteins  (Finley and  Chau,  1991; Varshavsky, 
1992). Ubiquitin is a small, 76-residue-long protein that is 
joined in a pseudo-peptide linkage through its COOH-ter- 
minal  carboxylic acid to the e-amino group of lysyl side 
chains in selectively recognized proteins. Ubiquitin modi- 
fication serves to mark a particular protein as a substrate 
for proteasomal degradation. Ubiquitin-regulated protein 
degradation is an essential step in a diverse number of cel- 
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processes such as DNA repair, transcriptional regulation, 
antigen presentation, signal transduction, and the cell cy- 
cle (Ciechanover, 1994; Hochstrasser, 1995, 1996). 
Although the lysosomal and proteasomal degradative sys- 
tems are generally considered to be functionally distinct, a 
possible link between these two systems is suggested by 
the  discovery of ubiquitinated cell surface proteins; the 
MEL-14 lymphocyte homing receptor  (Siegelman et al., 
1986), the PDGF receptor (Yarden et al., 1986; Mori et al., 
1992), the growth hormone receptor (Leung et al., 1987), 
the T cell receptor (Cenciarelli et al.,  1992),  and the IgE 
receptor (Paolini and Kinet, 1993) have been shown to be 
modified by ubiquitin. In some cases, the level of ubiquiti- 
nation was found to increase upon ligand binding (Mori 
et  al.,  1992; Cenciarelli  et  al.,  1992; Paolini  and  Kinet, 
1993). The function of the ubiquitin modification for these 
cell surface proteins remains uncertain. It has been vari- 
ously suggested to play a role in modulating receptor sig- 
naling (Paolini and Kinet, 1993), or in receptor endocyto- 
sis and turnover (Mori et al., 1992; Cenciarelli et al., 1992). 
Both the lysosomal and proteasomal degradative sys- 
tems have been clearly preserved through evolution to the 
yeast Saccharomyces cerevisiae. The genetics of the yeast 
ubiquitination pathway has been extensively studied, and 
recently, mutations that directly impair proteasome func- 
tion have been isolated as well (Jentsch and Schlenker, 
1995; Hochstrasser, 1995). The lysosomal system in yeast is 
embodied by the functionally equivalent organelle known 
as the vacuole (Jones, 1991). The vacuole is filled with var- 
ious hydrolases (proteases, lipases, phosphatase, etc.) and 
likewise serves  as a  potential endpoint of the yeast en- 
docytic pathway. Proteins that have been shown to be en- 
docytosed to, and degraded within, the vacuole include the 
two yeast pheromone receptors (Davis et al., 1993; Schan- 
del and Jenness, 1994),  a-factor (the peptide ligand for 
one of the two pheromone receptors)  (Singer and Riez- 
man, 1990), permeases for uracil (Volland et al., 1994) and 
inositol (Lai et al., 1995),  as well as the a-factor exporter 
Ste6p  (Kolling and  Hollenberg,  1994; Berkower  et  al., 
1994). 
Recent work suggests ubiquitin also as a possible modi- 
fication of yeast plasma membrane proteins. In the endo- 
cytosis-defective end3 and end4 mutant cell backgrounds, 
Ste6p was found to be trapped at the cell surface in a par- 
tially ubiquitinated state (Kolling and Hollenberg, 1994). 
Furthermore, in the ubc4 ubc5 background, mutants par- 
tially defective for ubiquitin conjugation to cellular sub- 
strate proteins, the rapid turnover of Ste6p was found to 
be slowed, suggesting a role for ubiqutination in Ste6p en- 
docytosis or turnover (Kolling and HoUenberg, 1994). Fo- 
cusing on the endocytic uptake of a-factor and its recep- 
tor,  recent  work  from  Hicke  and  Riezman  (1996)  has 
implicated  ubiquitin  in  this  process  as  well.  They find 
ligand-dependent ubiquitination of the receptor, as well as 
a substantial impairment of ligand uptake in the ubc4 ubc5 
background. Most significantly in terms of linking ubiqui- 
tination to endocytosis, they find that a  single lysine to 
arginine missense mutation in a  truncated version of the 
a-factor receptor simultaneously blocks both receptor ubiq- 
uitination and the receptor-mediated uptake of the a-fac- 
tor ligand. 
This report focuses on the a-factor receptor (encoded by 
the gene STE3). This is one of the two yeast pheromone 
receptors (the other being the a-factor receptor) enabling 
the cell-cell communication that precedes mating of the 
two haploid cell types, a and a  (Schultz et al., 1995). Each 
cell type secretes a unique peptide pheromone (a-factor by 
a cells, and a-factor by a  cells) and expresses at its surface 
the receptor for the pheromone secreted by the other cell 
type. Binding of pheromone to its cognate receptor acti- 
vates  an  intracellular  signal  transduction  pathway  that 
leads to the physiological alterations necessary for mating. 
These two receptors  are members of the seven trans- 
membrane segment (7-TMS) 1 receptor family, a large fam- 
ily that includes the retinal rhodopsins as well as receptors 
for many neurotransmitters (Strader et al.,  1994).  These 
receptors share two characteristics: (a) a common signal- 
ing mechanism, whereby intracellular signaling is initiated 
by the action of the liganded receptor on a conserved het- 
erotrimeric G  protein; and (b)  a  common overall struc- 
tural similarity, consisting of a hydrophobic core of seven 
transmembrane domains followed at the COOH terminus 
by  a  relatively large,  hydrophilic, cytoplasmic tail--the 
COOH-terminal domain (CTD). The hydrophobic core of 
the seven transmembrane domains is thought to mediate 
the primary receptor functions: ligand binding and G pro- 
tein coupling. The CTD appears to be largely regulatory 
(Dohlman et al., 1991). 
The pheromone receptors are subject to two modes of 
endocytosis---constitutive or ligand-indendent uptake, as 
well as a ligand-stimulated uptake (Jenness and Spatrick, 
1986; Chvatchko et al.,  1986; Davis et al.,  1993; Schandel 
and Jenness, 1994). In both cases, endocytosis delivers re- 
ceptor to the vacuole where it is degraded by vacuolar pro- 
teases. For the a-factor receptor, constitutive endocytosis 
is particularly rapid, and as a consequence, Ste3p is quite 
short-lived with a half-life at 30°C of ~20 min (Davis et al., 
1993).  Constitutive and ligand-dependent uptake may be 
mechanistically distinct, as suggested by the finding that 
the processes can be genetically separated. For instance, 
the  A365 receptor  mutant, which  removes  the  last  105 
amino  acid  residues  of  the  185-residue-long  CTD,  is 
wholly disabled for constitutive endocytosis, yet still com- 
petent for ligand-dependent uptake (Davis et al., 1993). 
In this report, we demonstrate that the a-factor receptor 
is subject to two distinct covalent modifications: phospho- 
rylation and ubiquitination. Phosphorylation, by analogy 
to other 7-TMS receptors  (Dohlman et al.,  1991),  likely 
functions to negatively regulate receptor activity. In terms 
of ubiquitination, we see a ligand-independent or constitu- 
tive  receptor  modification, as  well  as  ligand-dependent 
ubiquitination. In addition, cellular mutants, defective for 
this ubiquitination, impair the rate of the a-factor recep- 
tor's constitutive endocytosis and turnover. Based on our 
findings, a model is proposed wherein ubiquitin addition 
plays an initiating role, marking surface receptors destined 
for endocytic uptake. 
1. Abbreviations used in this paper. CTD, COOH-terminal domain, MM, 
minimal medium lacking methionine and cysteine; 7-TMS, seven trans- 
membrane segment. 
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Plasmids 
YEp96, YEpl05, and pES12 carry on a  TRP1/2 ~m yeast vector, CUP1- 
ubiquitin, CUPl-myc°tagged-ubiquitin, and the CUP1 promoter only (no 
downstream ubiquitin), respectively (Ellison and Hochstrasser, 1991). The 
BamHI to ClaI CUPl-ubiquitin-containing fragment of each was inserted 
between the same sites in the URA3/CEN vector YCp50 to make pND164 
(CUPl-ubiquitin), pND165 (CUPl-myc-ubiquitin), and pND167 (CUP1 
promoter only). Plasmids pUB23, pUB39, and pUB100 were provided by 
Vincent Chau (Wayne State University School of Medicine, Detroit, MI) 
and Dan Finley (Harvard Medicine School, Boston, MA) (Finley et al., 
1994).  pUB23  (URA3)  carries  a  ubiquitin-13-galactosidase fusion con- 
struct expressed from the GALl promoter, pUB39 (LYS2) carries CUP1- 
expressed ubiquitin, pUB100 carries a Ubil tail expression cassette (Fin- 
ley et al., 1989). 
Strains 
Genotype and source of the yeast strains used in this work are listed in Ta- 
ble I. Isogenic sets of strains were generated by specific gene replacement. 
Generally, the allele to be inserted is carried on the URA3 integrating 
plasmid pRS306 (Sikorski and Hieter, 1989).  A  unique restriction cut is 
used to direct integration of the plasmid at the homologous chromosomal 
site, creating a tandem Ura + integrant with wild-type and mutant allele 
separated by the plasmid vector sequences. Ura- colonies are isolated us- 
ing 5-fluoro-orotic acid (Boeke et al., 1984) and screened for their mutant 
phenotype. Mutant colonies are chosen only from individual integrants 
that yield a mixture of colonies showing either wild-type or mutant pheno- 
types, i.e., from bona fide tandem integrants. Such two-step gene replace- 
ments were used to convert STE3 to ste33.':LEU2  or to GAL1-STE3, to 
convert ste3A::LEU2  to GAL1-STE3A365,  to convert PEP4 to pep4A:: 
LEU2, and to convert pep4A::LEU2 to the unmarked deletion pep4A. To 
convert pep4A::URA3 to pep4A, essentially the same strategy was used, 
except the unmarked pep4A was carried on the LEU2 integrating plasmid 
pRS305 (Sikorski and Hieter, 1989). 
Antisera 
Rabbit antiserum raised against a TrpE-STE3 fusion protein (Clark et al., 
1988) was affinity purified using the fusion protein coupled to CNBr-acti- 
vated Sepharose 4B (Davis et al., 1993). A  second affinity-purified anti- 
Ste3p antibody was used exclusively for Fig. 2. This rabbit antibody, which 
was separately raised against the same TrpE-STE3 fusion protein and af- 
finity purified as above, except against a MalE-STE3 fusion protein (con- 
taining the same portion of Ste3p), shows less nonspecific cross-reaction 
on Western blots. 
Immunoblots 
Preparation  of protein extracts for Western blotting, SDS-PAGE, the 
transfer to nitrocellulose, and the antibody incubations were as described 
previously (Davis et al., 1993). Visualization of the antibody-reactive pro- 
teins was via the ECL system (Amersham Corp., Arlington Heights, IL). 
Phosphatase Digestion 
Protein extracts prepared as above in sample buffer (SB: 40 mM Tris/C1, 
pH 6.8, 5% SDS, 8 M urea, 0.1 mM EDTA, 1% 13-mercaptoethanol) were 
diluted 500-fold into I ml of the phosphatase digestion buffer (20 mM Ci- 
trate/Na, pH 6.0, 50 mM NaCI, 0.5 mM PMSF, I p.g/ml leupeptin, 1 ixg/ml 
pepstatin). Digestion was with 0.06 U (unless otherwise indicated) potato 
acid phosphatase (Boehringer Mannheim Corp., Indianapolis, IN) for 2 h 
at 25°C. Reactions were terminated and protein was precipitated with the 
addition of TCA to 10% and BSA (2 p,g/ml) as carrier. After 30 min at 
0°C, samples were centrifuged for 20 min in the microfuge at 4°C. Pellets 
were washed with acetone, dessicated, and then dissolved in 20 Ixl of SB 
for 5 rain at 65°C. 
Table L  Yeast Strains 
Strain  Genotype  Reference or Source 
227  MATa lysl  Herskowitz lab strain 
EG123  MATa ura 3 leu2 trpl can1 his4  Siciliano and Tatchell, 1984 
SM 1229  isogenic to EG 123, except mfal ::LEU2 tufa2:: URA3  Michaelis and Herskowitz, 1998 
SY1744  MATa STE3 pep4A::URA3 ura3 leu2 ade2-1°C  adel his6 trpl  am  Davis et al., 1993 
SY2601  MATa STE3 pep4A  This work; A 
SY2602  MATa ste3A::LEU2 pep4A  This work; A 
SY2635  MATa GAL1-STE3A pep4A  This work; A 
RHI44-3D  MATa ura3 leu2 his4 bar1-1  Raths et al., 1993 
RH268-1C  MATa end4-1  Raths et al., 1993; B 
NDY334  MATa STE3  This work; B 
NDY335  MATa STE3 end4-1  This work; B 
NDY341  MATa GAL1-STE3  This work; B 
NDY342  MATa GAL1-STE3  end4-1  This work; B 
NDY348  MATa GAL1-STE3 pep4A::LEU2  This work; B 
NDY351  MATa GAL1-STE3  end4-1pep4A::LEU2  This work; B 
NDY356  MATer GAL1-STE3 pep4A  This work; B 
NDY359  MATa GAL1-STE3  end4-1pep4A  This work; B 
SUB280  MATa lys2-801  leu2o3, 112 ura3-52 his3-A200 trpl-1 ubil::TRP1  Finley et al., 1994; C 
ubi2-A2::ura3 ubi3-Aub2 ubi4-A2::LEU2 [pUB39] [LIB  100] 
MATa [pUB23] [pUB 100] 
MATa STE3 [pUB39] [pUB100] 
MATa STE3 [pUB23] [pUB100] 
MATt~ STE3 pep4A [pUB39] [pUB100] 
MATa ste3A::LEU2 pep4A [pUB39] [pUB 100] 
MATa STE3 pep4A [pUB23] [pUB100] 
MATa STE3 his3-A2001eu2-3,112 ura3-52 1ys2-801 trpl-1 
MATa STE3 ubc4-Al::HlS3 ubcS-AI::LEU2 
MATa ste3A::LEU2 
MATa STE3 pep4A 
SUB312  Finley et al., 1994; C 
NDY365  This work; C 
NDY377  This work; C 
NDY421  This work; C 
NDY422  This work; C 
NDY426  This work; C 
MHY501  Chen et al., 1993 
MHY508  Chen et al., 1993; D 
NDY277  This work; D 
NDY346  This work; D 
Strains designated  A in the reference column are isogenic to SY1744. Strains designated  B are isogenic to RH 144-3D. Strains designated C are isogenic to SUB280. Strains desig- 
nated D are isogenic to MHY50I. 
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The  treatment  of intact  cells with  Pronase  (Calbiochem-Novabiochem 
Corp.,  La Jolla,  CA) and the subsequent extract preparation  were  de- 
scribed previously (Davis et al., 1993). 
Cell Labeling, Extract Preparation,  and 
Immune Precipitation 
An aliquot composed of 2-4 ×  107 cells from a culture growing in minimal 
medium lacking methionine and cysteine (MM), supplemented with 0.2% 
yeast extract, was collected by centrifugation, washed with 5  ml of MM 
lacking yeast extract (prewarmed to 30°C), centrifuged again, and resus- 
pended in MM lacking yeast extract at a density of 3  x  107 cells per ml. 
Cells were then incubated by end-over-end rotation in a 12-ml plastic tube 
for 20 min at 30°C, pulse-labeled for 10 min with the addition of [35S]me- 
thionine (DuPont-New England Nuclear, Wi!mington, DE) to 1 mCi/ml, 
and then chased with subsequent addition of methionine and cysteine to 
50 ixg/ml and yeast extract to 0.2%. At the indicated chase time points, al- 
iquots corresponding to 0.1 mCi were removed from the labeling mix, and 
extracts were prepared and immune precipitated using one of two differ- 
ent protocols. 
For  analysis of  turnover  under  ubiquitin-depletion  conditions, cells 
were collected by centrifugation, resuspended in 20 I~1 extraction buffer 
(EB; 40 mM Tris/Cl pH 8.0, 8 M urea, 0.1 mM EDTA, 1% 13-mercaptoeth- 
anol), transfered to a tube containing a 15-~1 volume of glass beads, and 
vortexed for 15 s. An additional 20 I~1 of EB supplemented with 5% SDS 
was added, and cell lysis was completed with an additional 1 rain of vor- 
texing. Samples were immediately heated at 100°C for 5  rain, and then 
stored at 0°C for several h until required for immune precipations. Before 
the immune precipitation, IgG from 20 i~1 of Ste3p antiserum was preab- 
sorbed to 20 mg protein A-Sepharose CL-4B (Pharmacia Fine Chemicals, 
Piscataway, N J) by end-over-end rotation for 1 h at 4°C in 1 ml of immune 
precipitation buffer (IP: 10 mM Tris/C1, pH 8.0, 0.1% Triton X-100, 2 mM 
EDTA). The resultant antibody-Sepharose complexes were washed with 
1 ml IP, and then resuspended finally in I ml IP. Just before initiating the 
immune precipitations, labeled extracts were again heated at 100°C for 5 
rain. Then, extracts were diluted with 0.9 ml IP with 0.5 mM PMSF, 1 ~g/ 
ml leupeptin, and 1 ~g/ml pepstatin, and centrifuged for 2 rain at 10,000 
rpm. The supernatant was then removed to a new tube containing 50 txl of 
the antibody-Sepharose complex and allowed to react for 3 h at 4°C. Im- 
mune complexes were washed once with 1 ml IP plus 0.1% SDS, and then 
the precipitated protein was eluted from the antibody-Sepharose by incu- 
bation for 5 min at 100°C in 40 ~1 EB containing 2.5% SDS. After centrif- 
ugation at 10,000 rpm for 2 rain, eluted protein was again diluted into 0.9 
ml IP with 0.5 mM PMSF, 1 ixg/ml leupeptin, and I ~g/ml pepstatin. A sec- 
ond round of immune precipitation  was then performed exactly as de- 
scribed above for the first, except in this case, immune complexes were 
washed  four  times with  IP  plus  0.1%  SDS.  Immune complexes were 
eluted by incubation for 5 rain at 100°C in 30 ~1 SB. 
For analysis of turnover in the ubc mutant backgrounds, cells at the in- 
dicated  times were  removed into 2  vol of ice-cold MM  that  contained 
0.2% yeast extract and 15 mM NaN3 and KF, and then left at 0°C for 20 
min. Cells were then collected with a microfuge spin, resuspended in 40 ixl 
oxalyticase buffer (OB:  1.4 M  sorbitol, 25  mM Tris/Cl, pH 7.5,  10 mM 
NaN  3, 10 mM KF, 2 mM MgCI2, 0.3% 13-mercaptoethanol) containing ox- 
alyticase (Enzogenetics, Corvallis, OR) at 600 U/ml, and then converted 
to spheroplasts by incubating at 30°C for 30 min. Spheroplasts were col- 
lected by microfugation, and then lysed with addition of 40 ixl SB contain- 
ing 2.5% SDS and incubation at 100°C for 5 min. Extracts were immune 
precipitated  as described above, except that only a  single round of im- 
mune precipitation was used. Immune complexes were washed four times 
with IP plus 0.1% SDS and eluted as described above. 
Quantitation 
The percentage of the receptor proteins either subject to ubiquitination, 
subject to digestion to external proteases, or remaining in a pulse-chase 
turnover at a  particular timepoint, was roughly estimated by coelectro- 
phoresis of the experimental samples, with dilutions of the sample corre- 
sponding to the receptor in its initial condition: for pulse-chase analysis, 
this would be receptor at the initial timepoint; for the external proteolysis 
protocol, this would be the mock-digested receptor; for estimation of frac- 
tion of receptor ubiquitinated, this would be the bulk unmodified recep- 
tor. Comparison of the undiluted sample in its final state (e.g., ubiquifi- 
nated  receptor  or  receptor  remaining after  proteolysis)  to  the  diluted 
samples allowed rough quantitation. 
Pheromone Treatment 
Cell cultures were treated with a-factor by addition of 0.1 vol of a 20-fold 
concentrated cell-free filtrate prepared from a saturated culture of EG123 
cells transformed with the a-factor overproduction plasmid pKK16 (Kuch- 
ler  et  al.,  1989).  Mock  a-factor  preparations  were  obtained  from  the 
isogenic mfal::LEU2 mfa2::URA3 strain SM1229.  Concentration of the 
pheromone filtrates  was by partial  lyophilization  yielding an ~10-fold 
concentration, followed by further concentration via ultrafiltration with 
Centriprep-10  (Amicon  Corp.,  Danvers, MA).  Growing  cultures were 
treated with 0.1 vol of the concentrated a-factor or mock a-factor filtrates. 
Results 
The a-Factor Receptor Is Phosphorylated 
and Ubiquitinated 
Serine/threonine phosphorylation functions in  the  adap- 
tive regulation of a number of 7-TMS receptors (Dohlman 
et al., 1991). This is best documented for the 13-adrenergic 
receptor and for the retinal rhodopsins where the negative 
regulation of signaling activity after stimulus exposure in- 
volves phosphorylation at  multiple serine and  threonine 
residues within the receptor's CTD by 13-adrenergic recep- 
tor kinase, or, in the case of rhodopsin, by the 13-adrenergic 
receptor kinase homolog rhodopsin kinase.  In yeast, the 
a-factor receptor has been shown to undergo serine/threo- 
nine  phosphorylation  at  multiple  sites  within  its  CTD, 
which has also been suggested to mediate the negative reg- 
ulation  of pheromone  receptor  activity  (Reneke  et  al., 
1988; Konopka et al., 1988; Zanolari et al., 1992; Chen and 
Konopka, 1996). Resting cells that have not been exposed 
to the a-factor ligand show a basal level of phosphoryla- 
tion of CTD serine and threonines. This level of receptor 
phosphorylation is increased upon a-factor exposure. 
The a-factor receptor appears in Western analysis as a 
disperse  cluster  of  bands  centered  around  a  molecular 
mass of 48 kD. Treatment of cellular protein extracts with 
potato  acid  phosphatase  resulted  in  the  collapse  of this 
cluster into a single gel band with an apparent molecular 
mass of 46.5 kD  (Fig. 1). Therefore, like the a-factor re- 
ceptor, the unstimulated a-factor receptor also is subject to 
basal phosphorylation. However, longer exposures of this 
Western blot revealed that not all of the receptor protein 
had been shifted by the phosphatase treatment to the 46.5- 
kD size. Two phosphatase-resistant species at 51 and at 57 
kD were observed, which together represent N10% of the 
total receptor protein. 
A  candidate for this phosphatase-resistant modification 
is ubiquitin. The addition of one or two 76-residue-long 
ubiquitin moieties might account for the discrete shift to 
the two phosphatase-resistant modified forms at 51 and 57 
kD. To test this, we have made use of the myc-epitope- 
tagged ubiquitin system developed by Ellison and Hoch- 
strasser (1991). myc-tagged ubiquitin has been shown to 
substitute efficiently for wild-type ubiquitin in the transfer 
to  several  known  substrates  for  ubiquitination  (Hoch- 
strasser et al.,  1991; Madura and Varshavsky, 1994).  Pro- 
tein extracts were prepared from cells expressing the nor- 
mal level of chromosomally-derived  ubiquitin (Fig. 2, lane 1), 
or from the isogenic cells overproducing either the 76-resi- 
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phosphorylation.  Protein extracts prepared from MA Ta pep4A 
cells (SY2601) were treated with increasing concentrations of po- 
tato acid  phosphatase as described  in Materials and Methods. 
Phosphatase-treated extracts were subjected  to SDS-PAGE and 
Ste3p was visualized by Western analysis using anti-Ste3p  anti- 
bodies. The milliunits used in each digestion are indicated  below. 
Two exposures of the same experiment are shown. (Left) Lighter 
exposure where  the  electrophoretic  shift  accompanying phos- 
phate removal is  apparent. As  equal  aliquots  of extract were 
treated with phosphatase, the light appearance of the duster of 
receptor species at 0 and at 6 milliunits of phosphatase likely re- 
flects a dispersion of receptor molecular weights due to heteroge- 
neous phosphorylation. At the highest  phosphatase concentra- 
tion (150 milliunits), some loss of receptor protein is seen, likely a 
reflection  of  low  level  protease  contamination  of  the  phos- 
phatase. In the darker exposure (right), the positions  of the two 
phosphate-resistant  modified  receptor  forms,  most  evident  in 
samples treated with  30 and 150 milliunits  of phosphatase, are 
shown (arrows). The high molecular weight bands without  adja- 
cent arrows are yeast proteins that cross-react with the Ste3p an- 
tiserum,  as they also appear in samples treated in parallel,  de- 
rived from a ste3A::LEU2 strain (data not shown). 
due-long wild-type ubiquitin (Fig. 2, lanes 2  and 4) or the 
90-residue-long  epitope-tagged ubiquitin  (Fig.  2,  lane 3) 
from the copper-inducible CUP1 promoter. The two CUP1- 
ubiquitin plasmids result in approximately fivefold overex- 
pression  of  either  wild-type  or myc-tagged  ubiquitin  in 
these  cells (data  not shown).  Because of the  slightly en- 
larged size of the tagged ubiquitin relative to the wild-type 
form,  protein  substrate  species  that  receive  the  myc- 
tagged ubiquitin should show slightly retarded gel mobility 
relative to the protein modified with the wild-type ubiq- 
uitin. As before, protein extracts prepared from these cells 
were  treated  with  phosphatase,  and  the  electrophoretic 
mobility of the  phosphatase-resistant modified receptors 
was  examined  by Western  analysis.  As  seen  previously 
(Fig. 1), two phosphate-resistant, higher molecular weight 
forms of the  a-factor receptor were observed in  extracts 
from wild-type cells (Fig. 2, lane 1) or from cells overex- 
pressing  wild-type  ubiquitin  from  the  CUPl-ubiquitin 
construct (Fig. 2, lanes 2 and 4). In extracts prepared from 
cells overexpressing the myc-tagged ubiquitin (Fig. 2, lane 3), 
these  modified  receptor  species  were  shifted,  showing 
slightly retarded gel mobility (Fig. 2, lane 3; compare with 
lanes 2 and 4). We conclude that the phosphatase-resistant 
receptor modification is, in fact, ubiquitination. 
An Endocytosis Blockade Increases Ubiquitination of 
Surface Receptor 
We have examined the effect of the end4 mutation on re- 
ceptor  ubiquitination.  Isolated  for  its  defect  in  the  en- 
docytic uptake of the a-factor ligand (Raths et al., 1993), 
end4 also has been demonstrated to block the endocytosis 
Figure 2.  Assessment of a-factor 
receptor ubiquitination.  Protein 
extracts  were  prepared  from 
MATer pep4A cells  (SY2601), 
carrying  one of three ubiquitin- 
expression  plasmids:  the vector 
control  plasmid  pND167  that 
carries only the CUP1 promoter 
but no downstream ubiquitin cod- 
ing sequences  (lane 1); pND164 
with CUPl-driven  wild-type ubiq- 
uitin (lanes 2 and 4); or pND165 
with CUPl-driven myc-tagged ubiquitin  (lane 3). Ubiquitin ex- 
pression from the CUP1 promoter was induced  in growing cul- 
tures with addition of 100 p.M CuSO4, 5 h before the collection of 
cells for extract preparation. Protein extracts were treated with 
potato acid phosphatase and subjected to SDS-PAGE, and Ste3p 
was visualized by Western analysis using anti-Ste3p  antibodies. 
The position of the phosphatase-resistant modified receptor spe- 
cies is indicated at right (brackets). 
of both Ste6p and the uracil permease (Kolling and Hol- 
lenberg, 1994; Berkower et al., 1994; Volland et al., 1994). 
In Fig. 3, the effect of end4 on the constitutive endocytosis 
of the a-factor receptor was assessed. The strains in  this 
experiment contain  an integrated  GAL1-STE3 allele re- 
placing the wild-type STE3 locus. Receptor was expressed 
during  2  h  of growth  on  galactose-containing  medium; 
then, after shutting off further synthesis of the receptor by 
glucose-mediated repression of the GALl promoter for 45 
min,  the  endpoint  localization  of  the  receptor  was  as- 
sessed. The cells used for this experiment were also pep4A. 
This mutation blocks the activation of vacuolar zymogens 
and therefore degradative turnover of the receptor. Thus, 
in the pep4A background, receptor delivered to the vacu- 
ole (the normal endpoint for Ste3p endocytosis) is stable. 
To assess localization,  the  susceptibility of receptor pro- 
tein in  intact yeast cells to added  extracellular proteases 
was measured. This provides a measure of the fraction of 
receptor proteins localized to the cell surface (Davis et al., 
1993).  Surface-localized receptor is digested, while inter- 
nalized receptor is resistant to the external proteases. In 
the  wild-type background  (END4+), receptor was  resis- 
tant to the added protease (Fig. 3). This is consistent with 
endocytotic delivery of preexisting surface receptor to the 
vacuole during the 45-rain period after termination of new 
receptor protein synthesis by glucose addition. In contrast, 
in  the  end4-1  mutant  background,  most  of the  receptor 
protein was found to be susceptible to the added external 
protease. This was evident both in  the  disappearance of 
full-length receptor and in the appearance of a characteris- 
tic proteolytic digestion product at 30 kD, a  membrane- 
protected  portion  of the  receptor  corresponding  to  the 
seventh  transmembrane  domain  plus  the  CTD  (Fig.  3; 
Davis et al., 1993). Therefore, as has been shown for other 
endocytosed  surface  proteins  in  yeast,  end4  deafly  dis- 
rupts the constitutive,  ligand-independent  endocytosis of 
the a-factor receptor as well. 
The end4-1 allele used in Fig. 3 is temperature sensitive: 
cell viability is lost  at 36°C.  a-Factor endocytosis in  this 
background  is  also  temperature  sensitive  (Raths  et  al., 
1993).  However, the effect of this mutation on the consti- 
tutive endocytosis of the a-factor receptor was found to be 
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exogenous  protease.  Cell cultures  from  two  isogenic  MATs 
GAL1-STE3 pep4A strains that differ only in being end4 mutant 
(NDY359) or wild-type END4 (NDY356) were grown for 2 h in 
the presence of 2% galactose, inducing synthesis of the receptor. 
Receptor synthesis was then shut off with the addition of 3% glu- 
cose, and 45 rain later, the abundance of receptor at the cell sur- 
face in these two backgrounds was assessed by subjecting intact 
cells to surface proteolysis  (+) or to mock protease  treatment 
(-), as described in the Materials and Methods. Subsequent to 
this, cells were lyzed and extracts were prepared and subjected to 
SDS-PAGE,  followed by Western  analysis with the  anti-Ste3p 
antibody. The  position of the  30-kD digestion product  is indi- 
cated at right (arrow). 
the same at 30°C (a temperature permissive for the growth 
of end4-1 cells) and at 36°C (Fig. 3; data not shown). Simi- 
lar impairment of endocytosis by this end4 allele  at per- 
missive temperatures was also noted for the constitutive 
endocytosis  of  Ste6p  (KoUing  and  Hollenberg,  1994; 
Berkower et al., 1994). 
Trapping the  receptor at the  cell  surface by the end4 
mutational block affects both phosphorylation and ubiq- 
uitination of the receptor. The mobility of the cluster of 
phosphorylated receptor species at 48 kD was found to be 
somewhat slower and more disperse for receptor isolated 
from end4 cells (Fig. 4 A), indicating that the receptor in 
the  end4 background is  subject to more extensive phos- 
phorylation. Ubiquitinated  receptor species  were  visual- 
ized after phosphatase treatment to remove heterogeneity 
in gel mobility due to phosphorylation. Clearly, both the 
presumptive  mono- and  di-ubiquitinated  receptor forms 
were found to be more abundant for receptor extracted 
from end4 vs wild-type cells (Fig. 4 B). Indeed, the di-ubiq- 
uitinated  form  was  especially  prominent  for  the  end4- 
derived  receptor.  Blocking  endocytosis,  therefore,  does 
not block receptor modification. Such a block would have 
been  expected  if  modification  occurred  exclusively  at 
some postsurface endocytic transport step. Instead, the ef- 
fect of end4 is to increase the level of these two modifica- 
tions, suggesting that both modifications may occur while 
the receptor is surface-resident. Increasing the receptor's 
surface residency time would increase its availability for 
surface-localized modifications. 
Figure 4.  The effect of end4 on receptor  phosphorylation  and 
ubiquitination. Protein extracts were prepared from the wild-type 
END4 (NDY356) and mutant  end4 (NDY359) isogenic pair of 
MATeL GAL1-STE3 pep4A strains cultured as described for Fig. 
3. (A) Effect of end4 on receptor phosphorylation levels. The two 
extracts were analyzed by Western analysis using the anti-Ste3p 
antibody. (B) Effect of end4 on receptor ubiquitination. Extracts 
were  treated  with potato acid phosphatase  (+)  or were  mock 
treated (-), and then subjected to SDS-PAGE followed by West- 
ern analysis with the  anti-Ste3p antibody. The positions of the 
two phosphatase-resistant, ubiquitinated receptor species evident 
upon phosphatase digestion are indicated at right (arrows). 
Cells Depleted for Ubiquitin Show Both 
Impaired Receptor Turnover and Receptor 
Retention at the Surface 
Ubiquitination  often functions to target  short-lived pro- 
teins for degradation by the proteosome. Although Ste3p 
is quite short lived with a half-life of ~20 min, its turnover 
is wholly dependent on vacuolar proteases and not on the 
proteosome (Davis et al.,  1993).  Nonetheless, ubiquitina- 
tion of Ste3p could play a role in signaling its rapid degra- 
dation. One possibility is that ubiquitin modification might 
mark surface receptor and target its endocytic transport to 
the vacuole. Alternatively, instead of affecting transport, 
ubiquitination could play an essential role in designating 
the endocytosed receptor as a  substrate for the vacuolar 
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proteins as substrates for the proteosome. To test if ubiq- 
uitin might participate in receptor endocytosis and turn- 
over, we  have made  use  of a  mutant  strain  background 
that allows cells to be depleted of the ubiquitin protein itself. 
The  strain  NDY377,  a  MAToL  derivative  of  SUB312 
(Finley et al., 1994), has all four of the wild-type chromo- 
somal ubiquitin  structural  loci deleted  or disrupted.  The 
sole source of ubiquitin  in these  cells is a  plasmid-borne 
ubiquitin-[3-galactosidase fusion construct expressed from 
the regulatable GALl  promoter (pUB23).  The ubiquitin 
fusion construct is processed in vivo to yield free ubiquitin 
(Bachmair et al., 1986). The intracellular pool of free ubiq- 
uitin in these cells, assessed by Western immunoblot with 
ubiquitin-specific  antibodies,  was  found  to  be  approxi- 
mately twofold lower than in a wild-type strain under ga- 
lactose growth conditions.  Free ubiquitin  levels were un- 
detectable by our methods 5 or 6 h after the imposition of 
a  glucose-mediated  block  to  further  synthesis  from  the 
GALl promoter (data not shown). We have also made use 
of the isogenic strain NDY365  in which a  plasmid-borne 
ubiquitin gene expressed from the CUP1 promoter (pUB39) 
replaces the GALl-driven  construct. Expression from this 
promoter is glucose insensitive, and thus, these cells serve 
as a control wherein ubiquitin is not depleted, but instead 
is produced  constitutively  at high levels. The  amount of 
free ubiquitin  as assessed by Western blotting was found 
to be about five- to tenfold greater in NDY365 cells than 
in wild type (data not shown). 
Ubiquitin is required for several cell-essential activities 
(Finley  et  al.,  1994;  Ciechanover,  1994;  Hochstrasser, 
1995).  Nonetheless, after the glucose-mediated repression 
of new ubiquitin  synthesis, NDY377  cells maintained ex- 
ponential cell growth for several hours (Fig. 5). Eventually, 
with sufficient depletion of ubiquitin, cell growth ceased 6 
to 7 h after glucose treatment (Finley et al., 1994; Fig. 5). 
Effects of this ubiquitin-depletion  regimen on the level 
of ubiquitin receptor modification were examined at vari- 
ous  times  after  the  imposition  of the  glucose-mediated 
block to new ubiquitin synthesis. In experiments with cells 
in which ubiquitin expression from the GALl-ubiquitin-f3- 
galactosidase plasmid is ongoing (e.g., before glucose addi- 
tion), we found no difference in the proportion of a-factor 
receptors that were ubiquitin modified compared with re- 
ceptor  extracted  from  the  CUPl-ubiquitin-expressing 
cells (data not shown). This was found to change after im- 
position of the block to new ubiquitin synthesis (Fig. 5, in- 
set). 2 h after glucose addition, the proportion of receptors 
found to be modified with ubiquitin was significantly less 
in  extracts  from  GALl-ubiquitin-f3-galactosidase  cells 
than from the  CUPl-ubiquitin  control cells. After 4  h  of 
ubiquitin  depletion,  no  ubiquitin-modified  receptor  was 
detected (Fig. 5, inset). 
To test if ubiquitin might participate in receptor endocy- 
tosis and turnover, we have examined the rate of receptor 
degradative turnover under the ubiquitin-depletion condi- 
tions. Turnover was examined during an interval 2.5-4 h 
after the imposition of the glucose-mediated block to new 
ubiquitin  synthesis in  NDY377  cells  (GALl-ubiquitin-f3- 
galactosidase) or in NDY365 cells (CUPl-ubiquitin).  This 
time frame was chosen as notable effects on receptor ubiq- 
uitination levels were seen during this interval (Fig. 5, in- 
Figure 5.  The effect of ubiquitin  depletion on cell growth and on 
receptor modification.  Ubiquitin-deletion  strains,  carrying  plas- 
mids  either  with  the  GALl-ubiquitin-f3-galactosidase  (strain 
NDY377) or the CUPl-ubiquitin construct (strain NDY365), were 
grown to early log-phase in medium containing  2% galactose  as 
the  sugar  source.  To  repress  synthesis  of ubiquitin  from the 
GALl promoter, 3% glucose was added (0 h). At 1-h intervals, 
culture  aliquots were removed, and culture  density was assessed 
through measurement of absorbance at k600. Growth curves are 
plotted as  a  function  of time after glucose  addition  for strain 
NDY365  (filled squares) and for NDY377  (filled circles). (Inset) 
Effects on receptor ubiquitination,  At the indicated  times after 
glucose  addition,  culture  aliquots  from  the  ubiquitin-deletion 
strain carrying  either the  GALl-ubiquitin-f3-galactosidase  plas- 
mid (G) or the CUPl-ubiquitin plasmid  (C) were removed, and 
protein extracts were prepared. Extracts were treated with potato 
acid phosphatase and subjected  to gel electrophoresis and then 
Western analysis using the anti-Ste3p  antibody.  Positions  of the 
ubiquitin-modified  receptor species are indicated  at left (arrows). 
set), while the growth rate of the NDY377 cells remained 
unimpaired (Fig. 5). Cells were in vivo labeled for 10 min 
with  [35S]methionine,  and  then  chased  for up  to  90  rain 
with cold methionine. To follow the fate of newly synthe- 
sized  receptor,  extracts were  prepared from the  labeled 
cells at different chase time points, and the receptor pro- 
tein was purified via immune precipitation (Fig. 6). For the 
NDY365 control cells, rapid Ste3p turnover was seen, con- 
sistent with the previously measured receptor half-life of 
~20 min at 30°C (Davis et al., 1993). This contrasts sharply 
with the result observed for NDY377 cells. Under condi- 
tions of ubiquitin  depletion, Ste3p turnover was substan- 
tially slowed; the receptor half-life was estimated to be ~2 h. 
Therefore, we conclude that receptor turnover depends on 
the level of available ubiquitin within the cell. 
In addition to the effect on receptor turnover, it was also 
apparent in Fig. 6 that the depletion of ubiquitin also per- 
turbs Ste3p expression, evident in terms of the decreased 
incorporation of label into Ste3p for the initial time point 
of the NDY377  cells (Fig.  6; compare intensity of Ste3p 
band at the 1-min time point between the CUPl-ubiquitin 
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The MATer ubiquitin-deletion  strains,  carrying  plasmids  either 
with the CUPl-ubiquitin construct  (strain NDY365) or with the 
GALl-ubiquitin-B-galactosidase construct  (strain NDY377), were 
grown initially in minimal synthetic medium containing 2% galac- 
tose. Glucose was added to 3%, and then 2.5 h later, cells were la- 
beled for 10 min with  [35S]methionine. Excess cold methionine 
and cysteine was then added, and ceils were chased for times indi- 
cated. At this point, aliquots were removed and protein extracts 
were prepared. Extracts were immune precipitated with  Ste3p- 
specific antiserum and subjected  to SDS-PAGE, and the result- 
ing purified Ste3p was visualized with autoradiography. As a con- 
trol  for  proteins  precipitated  through  cross-reaction  with  the 
Ste3p antiserum,  an isogenic MA Ta strain  (no Ste3p expression) 
SUB312 was processed in parallel. 
posed  at  the  cell  surface is  susceptible  to  digestion;  en- 
docytosed receptor that has been removed from the sur- 
face resists digestion (Davis et al., 1993). After the protease 
digestion, extracts were prepared, and the labeled recep- 
tor was purified for gel electrophoresis by immune precip- 
itation. As a control for the maintenance of cell integrity, 
we have also monitored by immune precipitation the di- 
gestion of the cytoplasmic enzyme phosphoglycerol kinase 
and  found  no  evidence  of digestion  at  any  of the  time 
points (data not shown). 
In the control cells where ubiquitin is produced constitu- 
tively from the CUP1 promoter, we found that the recep- 
tor was maximally at  the  surface  10 min  after synthesis 
(Fig. 7). This was evident both in terms of the diminution 
of the receptor protein band (>50% susceptibility) and by 
the  appearance  of a  digestion  product  at  30  kD,  corre- 
sponding to the  cytoplasmic tail plus seventh transmem- 
brane domain (the Ste3p antiserum was raised against the 
cytoplasmic tail domain). At longer times after synthesis, 
and GALl-ubiquitin-LacZ samples). This difference likely 
reflects effects on the  rate  of Ste3p synthesis, not  Ste3p 
turnover: (a) loss of labeled receptor to vacuolar turnover 
is generally not a  factor at such early timepoints, and (b) 
because  these  differences  in  Ste3p  levels  are  retained 
when vacuolar turnover is blocked in pep4A cells (data not 
shown). Furthermore, this difference in Ste3p expression 
does not reflect a generalized impairment of protein syn- 
thesis caused by the ubiquitin depletion: the level of incor- 
poration  of  [~SS]methionine  both  into  total  protein  and 
into the cytoplasmic enzyme phosphoglycerol kinase was 
found to be unimpaired  (data not shown).  Therefore ef- 
fects of the ubiquitin depletion on Ste3p expression likely 
are specific. 
Turnover of a-factor receptor is by vacuolar proteases 
and  requires  endocytic  transport  of the  receptor  to  the 
vacuole.  The  block  imposed  upon  ubiquitin  depletion 
could possibly result from a  failed recognition of the re- 
ceptor as substrate for vacuolar proteases, or alternatively, 
transport to the vacuole could be impaired. We have again 
made use of a whole cell proteolysis protocol to assess sur- 
face localization of the receptor under conditions of ubiq- 
uitin depletion. For these experiments, pep4A versions of 
the  ubiquitin-delete  strains  were  used,  allowing  assess- 
ment of localization in  absence of any ongoing receptor 
degradation.  Cells  harboring  either  GALl-ubiquitin-fS- 
galactosidase  plasmid  (NDY426)  or  the  CUPl-ubiquifin 
plasmid (NDY421) were pulse-labeled in vivo and chased 
as described above. As for the turnover experiment (Fig. 
6), cell labeling was for 10 min and was initiated 2.5 h after 
the glucose-imposed block to new ubiquitin synthesis. At 
intervals after the pulse-labeling of newly synthesized re- 
ceptor, culture aliquots were removed and treated with the 
energy poisons (10 mM NaN3 and  10 mM KF) to block 
further transport. These intact cells were then subjected to 
digestion with added proteases. Only receptor that is ex- 
Figure 7.  The effect of ubiquitin  depletion on the endocytic re- 
moval of receptor protein from the cell surface, pep4A versions of 
the ubiquitin-deletion  strain,  carrying  plasmids  either with  the 
CUPl-ubiquitin construct  (strain  NDY421)  or with the GAL1- 
ubiquitin-13-galactosidase construct (strain NDY426), were grown 
and in vivo labeled with [35S]methionine 2.5 h after a glucose-medi- 
ated block to new ubiquitin synthesis as described for Fig. 6. Sam- 
ples were taken 10, 30, 60, and 120 min after the initiation  of the 
chase. Cells were digested with 1 mg/ml Pronase (+), or mock di- 
gested with no protease (-) for 1 h at 37°C. Extracts were pre- 
pared and immune precipitated using Ste3p-specific  antiserum. 
To identify  those proteins that precipitate due to cross-reaction 
with the antiserum, NDY422, an isogenic ste3A':LEU2 derivative 
of  NDY421  was  processed  in  parallel.  Results  from  strain 
NDY421  (CUPl-ubiquitin) are  shown  in  the  top panel,  while 
those  from  NDY426  (GALl-ubiquitin-f~-galactosidase)  are 
shown below. (Right) Positions  of full-length  Ste3p (arrow), the 
30-kD CTD Ste3p digestion  product (arrowhead), and a species 
cross-reactive  with  the  Ste3p  antiserum also  precipitated from 
ste3A::LEU2 cells (hash mark). 
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external proteases, consistent with its removal from the 
cell surface by endocytosis. Changing protease susceptibil- 
ity presumably reflects changing localization for the recep- 
tor: cytoplasmic synthesis, delivery to the cell surface, and 
finally, endocytosis to the vacuole. Although the CUP1- 
ubiquitin  control  for  these  experiments  constitutively 
overexpresses  ubiquitin  (five-  to  tenfold), the  transient 
surface residency of Ste3p observed in these cells is consis- 
tent with kinetics of endocytosis, as previously assessed in 
strains with wild-type levels of ubiquitin. In such wild-type 
strains, receptor was found to be maximally available at 
the cell surface 10 to 30 rain after synthesis (Davis et al., 
1993). 
Under ubiquitin-depletion conditions, i.e., in the GAL1- 
ubiquitin-I~-galactosidase  background  (strain  NDY426), 
newly synthesized receptor was again found to be largely 
surface localized at the earliest time point (Fig. 7; 10 min). 
At longer times after synthesis, however, obvious effects 
on receptor traffic were apparent (Fig. 7).  At the 30-min 
time point, the receptor showed somewhat increased pro- 
tease susceptibility relative to the first time point, consis- 
tent with further delivery of the newly synthesized receptor 
to the surface during this interval (10-30 min after synthe- 
sis). Once delivered to the surface, slight if any loss of sus- 
ceptibility to the external proteases was evident over the 
next 90 min (Fig. 7; compare 30-, 60-,  and i20-min time 
points). The bulk of the receptor population remained sur- 
face localized fully 2 h after its biosynthesis. Thus, under 
these ubiquitin-depletion conditions, the constitutive en- 
docytosis of  Ste3p,  which  is  normally quite  rapid,  was 
found to be drastically impaired if not blocked altogether. 
Therefore we conclude that the normal rate of receptor 
constitutive endocytosis depends on the availibility of suf- 
ficient levels of intracellular ubiquitin. 
Involvement of Two Ubiquitin-Conjugation Functions 
in Receptor Ubiquitination and Turnover 
The  E2  enzymes, encoded by the  UBC genes in yeast, 
function in substrate recognition for ubiquitination and in 
the enzymatic addition of the ubiquitin moiety. 10 distinct 
UBC genes have been identified in yeast to date (Chen et al., 
1993).  This  diversity  in  ubiquitin-conjugating  enzymes 
likely reflects the diversity of substrate proteins that must 
be recognized for ubiquitination. We were interested to 
know if any of these  UBC functions participated in the 
ubiquitination of the a-factor receptor. Work on another 
cell surface membrane protein, the a-factor exporter pro- 
tein Ste6p had implicated UBC4 and UBC5 as being in- 
volved  in  the  rapid  vacuolar  turnover  of  this  protein 
(Kolling and  Hollenberg,  1994).  Ubc4p  and  UbcSp  are 
close sequence homologs and appear at least in part to be 
functionally redundant  (Seufert  and  Jentsch,  1990).  In 
ubc4A ubc5A cells, turnover of Ste6p that normally has a 
half-life of ~20  min was found to be slowed by two- to 
threefold (Kolling and Hollenberg, 1994). 
In light of the above findings, we have asked if UBC4 
and UBC5 might participate in the ubiquitination of Ste3p. 
Immunoblots of Ste3p  extracted from either the ubc4A 
ubc5A cells or from cells of the isogenic wild-type strain 
showed  several  obvious  differences.  The  ubc4A  ubc5A 
strain showed a 2.5-fold over accumulation of the receptor 
protein as well as increased Ste3p phosphorylation (Fig. 8). 
Similar effects on both Ste3p quantity and phosphoryla- 
tion were noted previously for end4 cells (Fig. 4 A), sug- 
gesting that like end4, the ubc4A ubc5A mutations might 
exert their effects through impairment of a-factor receptor 
endocytosis. To examine the effect of these mutations on 
receptor ubiquitination, extracts were treated with phos- 
phatase and diluted so that equivalent amounts of recep- 
tor could be compared. Clearly, the ubc4A ubc5A  muta- 
tions lead to a significant decrease in the proportion of the 
receptor  that  is  ubiquitin  modified.  This  suggests  that 
Ubc4p and Ubc5p may play a direct role in the recognition 
of Ste3p as a substrate for ubiquitination. 
We  have  also  investigated  the  involvement  of  the 
UBC4/UBC5  functions in receptor turnover. Ste3p turn- 
over was compared in three isogenic MATa strains: (a) a 
wild-type strain, (b) apep4A strain, and (c) a ubc4A ubc5A 
strain. Cells were labeled in vivo for 10 min with [35S]me- 
thionine, and then chased with cold methionine for the 
times indicated (Fig. 9). In the wild-type background, the 
usual rapid turnover is apparent. In the pep4 cells, turn- 
over is blocked. In the ubc4A ubc5A background, turnover 
was found to be impaired, showing a receptor half-life of 
N45 min--two- or threefold slower than in wild-type cells. 
Thus, decreased receptor ubiquitination is correlated with 
decreased receptor turnover, again suggesting a possible 
causal link between the two processes. 
In addition to the ubc4A ubc5A double mutant, we have 
also  tested  Ste3p  turnover  in  other  ubc  mutant  back- 
grounds.  Consistent  with  the  functional redundancy of 
UBC4  and  UBC5,  no effect on Ste3p  turnover was ob- 
served in a  ubc4A  ubc6A  mutant background  (data not 
shown). Furthermore, a temperature-sensitive cdc34 (ubc3) 
strain showed no Ste3p turnover defect at its nonpermis- 
sive temperature (data not shown). In addition, cells de- 
leted for the E3 function UBR1 did not manifest impaired 
Ste3p turnover (data not shown). 
a-Factor-induced Ubiquitination of the Receptor 
In addition to ligand-independent, constitutive endocyto- 
sis, the a-factor receptor is also subject to ligand-depen- 
Figure 8.  The effect of ubc4A ubc5A mutations on receptor mod- 
ification. Protein  extracts  were  prepared  from  the  wild-type 
MATer strain  MHY501 and  the isogenic ubc4A ubc5A strain 
MHY508. (Left) Samples are subjected to Western analysis with 
affinity-purified Ste3p-specific antibody. (Right) Extracts  were 
treated with potato acid phosphatase, and the ubc4A ubc5A sam- 
ple was diluted 2.5-fold to normalize levels of Ste3p for Western 
analysis. 
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ubcSA mutations on the turn- 
over of the a-factor receptor. 
Cell  cultures  from  three 
isogenic MATc~ strains were 
labeled  in  vivo  for  10  min 
with  [35S]methionine:  (a) 
wild-type  (MHY501),  (b) 
pep4A::LEU2 (NDY346), or 
(c) ubc4A ubc5A (MHY508). 
Samples  were  taken  1,  45, 
and 90 min after initiation of 
the chase, and  then extracts 
were prepared. Extracts were 
immune  precipitated  with 
Ste3p-specific antiserum  and 
subjected to SDS-PAGE,  and the resulting purified Ste3p was visualized with autoradiography.  As a control for the cross-reaction of 
the Ste3p antiserum, an isogenic ste3A (NDY277) cell culture was labeled and processed in parallel (ste3A). The position of Ste3p is in- 
dicated at right (arrow). Proteins present in the ste3A lane are cross-reactive species that contaminate all the immune precipitations. 
dent endocytosis (Davis et al.,  1993).  Ligand-dependent 
uptake is most conveniently studied using a mutant recep- 
tor protein that is wholly defective for rapid constitutive 
endocytosis. STE3A365 encodes a truncated version of the 
receptor missing the COOH-terminal 105 amino acids of 
the 185-residue-long CTD. In the absence of added a-fac- 
tor ligand, Ste3A365p does not undergo endocytosis, and 
instead  it  accumulates  at  the  cell  surface  (Davis  et  al., 
1993). However, when presented with a-factor, Ste3A365p 
was found to undergo internalization that, like the consti- 
tutive process, delivers receptor to the vacuole. We have 
exploited this mutant receptor to investigate the possible 
involvement  of  phosphorylation  and  ubiquitination  in 
ligand-dependent endocytosis. Cells of the MA TeL GAL1- 
STE3A365 pep4A strain SY2635 were grown on galactose- 
containing medium for 2 h, allowing receptor expression 
and accumulation at the cell surface. 30 min after termi- 
nating new receptor synthesis with the addition of 3 % glu- 
cose, cells were treated for 90 min with or without a-factor. 
Comparison  of receptor protein  extracted  from  phero- 
mone-treated vs the mock-treated cells showed that the 
a-factor  treatment  led  to  increased  phosphorylation  of 
Ste3A365p  (Fig.  10 A).  Ligand-dependent  phosphoryla- 
tion generally observed for 7-TMS receptors is thought to 
play an adaptive role in regulating receptor activity (Dohl- 
man et al., 1991). 
To investigate ligand-dependent changes in ubiquitina- 
tion, we have again used the epitope-tagged ubiquitin con- 
structs in combination with potato acid phosphatase treat- 
ment. SY2635 cells carried one of three different plasmids: 
(a) empty plasmid (pND167), (b) plasmid containing the 
CUPl-driven wild-type ubiquitin (pND164), or (c) plasmid 
with  the  CUPl-driven  myc-tagged  ubiquitin  (pND165). 
Cells were grown and treated with a-factor pheromone for 
90 min  exactly as  described above. We have previously 
shown that this treatment results in quantitative endocyto- 
sis of Ste3A365p to the vacuole (Davis et al., 1993). Phero- 
mone treatment induced two phosphatase-resistant modi- 
fied receptor species at 38 and 45.5 kD (Fig. 10 B, vector 
only lanes). In the exposure shown, only the 38-kD species 
is evident. When cellular levels of ubiquitin were increased 
from the CUPl-ubiquitin plasmid pND164, the proportion 
of the receptor present as these modified species also in- 
creased  (Fig.  10  B,  wt ubiq  lanes).  For  these  cells,  in- 
creased modification was seen even for the mock-treated 
(i.e, no a-factor) cells, where a modified species at 38 kD is 
evident. Phosphatase-resistant modification was again fur- 
ther increased with a-factor treatment; more of the 38-kD 
species was evident, as well as a 45.5-kD species. The find- 
ing that the extent of modification is sensitive to the level 
of ubiquitin available in the cell suggests that this a-factor- 
induced modification is in fact ubiquitin. This interpretation 
was solidified when the same experiment was performed 
in  cells  that  overproduce  the  epitope-tagged  ubiquitin 
(from pND165).  In  this  case,  modified receptor species 
with slightly slowed electrophoretic mobilities were evi- 
dent (Fig. 10 B, myc-ubiq lanes), consistent with modifica- 
tion  by  the  enlarged,  90-residue-long  tagged  ubiquitin. 
Therefore, we conclude that  the a-factor-induced, phos- 
phatase-resistant modification is indeed ubiquitination. 
The  apparent  molecular weight  of the  two  ubiquitin- 
modified forms of the receptor suggest that they represent 
the mono- and di-ubiquitinated forms. Most of the phos- 
phatase-treated Ste3A365p migrates at 29.5 kD, while the 
two modified forms are at 38 and 45.5 kD. In cells express- 
ing the myc-tagged  ubiquitin, the lower of the two modi- 
fied receptor forms is present as a doublet--one that mi- 
grates  at  38  kD  and  one  at  the  39.5-kD  position.  This 
higher molecular weight species probably corresponds to 
the addition of a single myc-tagged  ubiquitin, while the 38- 
kD species represents ubiquitination by endogenous, chro- 
mosomally expressed wild-type ubiquitin. At the di-ubiq- 
uitinated position, a  triplet cluster of receptor species is 
evident (Fig.  10 B). This is to be expected for a  protein 
modified with two ubiquitin moieties, as there are three 
combinations  possible:  (a)  two  wild-type ubiquitin  moi- 
eties, (b) one wild-type and one myc-tagged  ubiquitin, or 
(c) two myc-tagged  ubiquitins. 
Discussion 
a-Factor Receptor Is Subject to Constitutive and 
Ligand-dependent Phosphorylation 
The a-factor receptor is  subject to two  distinct covalent 
modifications: phosphorylation and ubiquitination.  Phos- 
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ligand-dependent  phospho- 
rylation  and  ubiquitination 
of the  tail-truncated  recep- 
tor,  Ste3A365p.  MA Ta 
GAL1-STE3A365  pep4A 
cells (SY2635), carrying one 
of  three  ubiquitin-expres- 
sion  plasmids  were  induced 
for ubiquitin expression with 
100 ~xM CuSO 4 for 2.5 h: (a) 
pND164  with  CUPl-driven 
wild-type ubiquitin  (wt), (b) 
pND165  with  CUPl-driven 
myc-tagged ubiquitin  (myc- 
ubiq), or (c) the vector con- 
trol  plasmid  pND167  that 
carries  only the  CUPI  pro- 
moter  but  no  downstream 
ubiquitin coding sequences (vector  only). Subsequently, 2% galactose was added for 90 min to induce synthesis of the tail-truncated re- 
ceptor Ste3A365p. New receptor synthesis was then repressed  with 3% glucose for 30 min, and then ceils were treated with a-factor 
(+ a) or mock treated (-) for 90 min. (A) Effect of pheromone treatment on receptor phosphorylation  levels. Extracts prepared from 
SY2635 cells carrying pND167, grown and exposed to a-factor as described above, were subjected to SDS-PAGE and Western analysis 
with the anti-Ste3p antibody. (B) Effect of pheromone treatment on receptor ubiquitination. Extracts from SY2635 cells, carrying the 
three ubiquitin expression plasmids cultured  and pheromone treated as described above, were digested with phosphatase,  and then 
subjected to SDS-PAGE and Western analysis with the anti-Ste3p antibody. The positions of the ubiquitin-modified receptor forms are 
indicated with bars at right, while the positions of modified forms that likely involve the myc-tagged ubiquitin are indicated with ar- 
rows. 
phorylation  of the  serine/threonine-rich  CTD  has  been 
demonstrated for a number of 7-TMS receptors (Dohlman 
et al.,  1991), including the Ste3p counterpart, the a-factor 
receptor (Reneke et al., 1988; Zanolari et al., 1992). Herein 
we show that the a-factor receptor is subject to a constitu- 
tive or basal level of phosphorylation, and as with other 
7-TMS  receptors,  ligand  stimulation  leads  to  increased 
phosphorylation. Ligand-induced phosphorylation occurs 
for the A365 tail-truncated receptor (Fig. 10) as well as for 
the wild-type a-factor receptor (Davis, N.G., unpublished 
results). For retinal rhodopsin and the 13-adrenergic recep- 
tor, CTD phosphorylation is part of a mechanism for rapid 
adaptive  regulation  of  the  receptor's  signaling  activity 
(Dohlman  et  al.,  1991).  We  would  suggest,  therefore, a 
similar role for phosphorylation in the regulation of the 
a-factor receptor.  Consistent  with  such  a  role, we  have 
previously  demonstrated  that  a-factor  receptors  with  a 
truncated CTD, and therefore, missing potential phospho- 
rylation sites, show a heightened, supersensitive response 
to ligand (Boone et al.,  1993). Based on similar findings, a 
role for CTD phosphorylation in receptor desensitization 
has also been suggested for the a-factor receptor (Reneke 
et  al.,  1988;  Konopka  et  al.,  1988;  Chen  and  Konopka, 
1996). 
Involvement of Ubiquitination in Surface Protein 
Endocytosis and Turnover 
Ubiquitination has been identified as a possible modifica- 
tion for surface membrane proteins both in  mammalian 
cells (Siegelman et al., 1986; Yarden et al., 1986; Leung et al., 
1987; Mori et al., 1992; Cenciarelli et al., 1992; Paolini and 
Kinet, 1993) and in yeast (Kolling and Hollenberg, 1994; 
Hicke and  Riezman,  1996).  For mammalian  cell surface 
receptors, the function of this modification has remained 
uncertain. In yeast, four pieces of evidence now point to 
the involvement of ubiquitination in endocytosis. First, a 
multicopy plasmid carrying the yeast UBI4 gene, encoding 
four tandem copies of the ubiquitin protein, was found to 
suppress  lethality associated with a  mutant  allele of the 
clathrin heavy chain gene  (Nelson  and  Lemmon,  1993). 
Overexpression  of  ubiquitin  therefore  compensates  for 
some clathrin-associated defect. It is notable in this regard 
that  a  partial  requirement  for yeast  clathrin  in  the  en- 
docytic uptake of the pheromone receptors has been dem- 
onstrated (Payne et al., 1988; Tan et al., 1993).  Second, a 
possible role for ubiquitination in the endocytosis and vac- 
uolar degradation  of two  yeast cell surface  transporters 
has been suggested--the a-factor exporter protein, Ste6p, 
and the ATP-binding cassette multidrug transporter pro- 
tein,  Pdr5p  (Kolling  and  Hollenberg,  1994;  Egner  and 
Kuchler, 1996). Like the a-factor receptor, both Ste6p and 
Pdr5p undergo a rapid, constitutive endocytosis that deliv- 
ers surface protein to the vacuole for degradative turnover 
(KoUing and Hollenberg, 1994; Berkower et al.,  1994; Eg- 
ner et al.,  1995), and both have found to be ubiquitinated 
(Kolling and Hollenberg, 1994; Egner and Kuchler, 1996). 
In addition, a  threefold impairment in the rate of Ste6p 
turnover was observed in a ubc4A ubc5A mutant cell back- 
ground  (Kolling and  Hollenberg,  1994).  Third,  work  on 
the general amino acid permease Gaplp previously identi- 
fied the gene NPI1 as required for the regulated inactiva- 
tion of surface permease activity (Grenson, 1983).  Recent 
analysis  of NPI1  revealed  that  it  is  identical  to  RSP5, 
which apparently encodes a ubiquitin E3 function (Hein et 
al.,  1995). In addition to effects on Gaplp activity, these 
authors also showed that the npil/rsp5 mutation impairs 
the vacuolar turnover of Fur4p, the uracil permease. Fi- 
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involvement for ubiquitin in ligand-dependent endocytosis 
of this receptor  (Hicke  and  Riezman,  1996).  They find 
both  a  ligand-dependent ubiquitination of the  receptor 
and a substantial impairment of ligand uptake in the ubc4 
ubc5 mutant background. Most significantly, in terms of 
linking receptor ubiquitination to endocytosis, they f'md 
that  a  single  lysine  to  arginine  mutation  in  a  severe 
COOH-terminally truncated version of the a-factor recep- 
tor simultaneously blocks receptor ubiquitination as well 
as the receptor-mediated uptake of the a-factor ligand. 
These observations have now been extended to the en- 
docytosis and turnover of the a-factor receptor. Our work 
that focuses on the constitutive uptake of this receptor com- 
plements the analysis of Hicke and Riezman (1996), which 
concentrated on the ligand-dependent uptake of a-factor 
receptor. Under conditions in which constitutive endocy- 
tosis is proceeding normally, ~10% of the receptor protein 
is present as ubiquitin-modified species (apparent either as 
the mono- or di-ubiquitinated forms). Furthermore, this 
low level of ubiquitination is seen to increase in an end4 
mutant cell background where the normal constitutive en- 
docytosis of the receptor is blocked and the receptor accu- 
mulates at the cell surface. This suggests that ubiquitina- 
tion may occur in wild-type cells during the window of 
time while the receptor is surface-resident. 
To test for the potential involvement of ubiquitination 
in the constitutive endocytosis and turnover of the recep- 
tor, we have made use of cells in which all of the chromo- 
somal copies of the ubiquitin structural gene have been 
deleted, and which survive by virtue of an episomal copy 
of the  ubiquitin gene  conditionally expressed  from the 
GALl promoter. The depletion of ubiquitin by glucose re- 
pression of the GALl promoter results in very striking ef- 
fects on both receptor turnover and localization. Receptor 
turnover is drastically impaired with its half-life increasing 
from 20 min to ~2 h. Accompanying the turnover effects is 
a dramatic change in localization. In wild-type cells, resi- 
dency of the a-factor receptor at the surface is short lived, 
being maximally present at the surface 10 to 30 min after 
synthesis (Davis et al.,  1993).  Under conditions of ubiq- 
uitin depletion, the majority of the receptor was found to 
be surface retained even 2 h after its synthesis. Therefore, 
it appears that the impaired turnover of the receptor is a 
consequence of its impaired endocytosis. 
Based on results with the a-factor receptor, Hicke and 
Riezman (1996) have suggested that the ligand-dependent 
ubiquitination of this receptor is a requirement for initiat- 
ing its ligand-dependent endocytic uptake. Consistent with 
this,  using  the  truncation  mutant STE3A365, we  see  a 
ligand-dependent ubiquitination that accompanies ligand- 
stimulated uptake. The bulk of our analysis, however, has 
focused on ligand-independent processes,  and based on 
these results, we would like to suggest that ubiquitin may 
play an essential role in initiating constitutive uptake as 
well.  Conceptually, attachment  of ubiquitin  provides  a 
way of marking surface receptor, providing a  molecular 
flag for recognition by the cell's endocytic apparatus. In 
this scenario, the under-ubiquitination of the receptor that 
accompanies ubiquitin depletion would be insufficient to 
trigger uptake. We cannot eliminate the possibility that 
the effects of ubiquitin depletion on receptor endocytosis 
are  indirect.  For instance,  some  component of the  en- 
docytic apparatus could, in theory, be regulated through 
ubiquitination. Furthermore, since ubiquitin is an essential 
protein, its depletion eventually leads to diverse cellular 
processes being shutdown--among these may be endocy- 
tosis. It is notable in this regard that our measurements of 
receptor  turnover  and  endocytosis  occurred  relatively 
soon after the imposition of the glucose-mediated block to 
new ubiquitin synthesis. At this time, cells still showed ex- 
ponential growth kinetics as well as unimpaired protein 
synthesis. It is unlikely that the ubiquitin depletion results 
in a generalized impairment of cellular membrane traffic; 
impaired secretory flow of membrane would be expected 
to have a fairly direct and immediate effect on cell growth 
kinetics. Furthermore, the protease-susceptibility protocol 
used to measure receptor residency times (Fig. 7) can also 
be used to assess the kinetics with which newly synthesized 
receptor is delivered to the surface. In such experiments, 
rates of appearance of the newly synthesized receptor at 
the cell surface, a measure of secretory pathway function, 
were found to be roughly equivalent in the GALl-ubiq- 
uitin and control strains under the glucose-repression con- 
ditions (data not shown). Therefore, the effects of ubiq- 
uitin  depletion  appear  to  be  specific for  the  endocytic 
trafficking of the receptor. 
Involvement of Ubiquitin E2 and E3 Activities in the 
Ubiquitination of Cell Surface Proteins 
In addition to the ubiquitin structural genes and the yeast 
E1 activity (encoded by UBA1), which is required for the 
initial activation of newly synthesized ubiquitin, the cell 
expresses a  large number of additional enzymatic activi- 
ties, E2 and E3 enzymes, that mediate both substrate rec- 
ognition and the actual conjugation of the ubiquitin moi- 
eties to the substrate protein. The diverse number of these 
activities is thought to reflect the diversity of substrates 
that the ubiquitin system must normally recognize. Which 
of these are involved in the ubiquitination of the phero- 
mone receptors? To date, 10 distinct UBC genes encoding 
E2 activities have been identified (Chen et al., 1993). Our 
data on the ubiquitination of Ste3p suggest a central role 
for Ubc4p and Ubc5p. ubc4A ubc5A cells show severe dim- 
inution  of  Ste3p  ubiquitination  and  also  slowed  Ste3p 
turnover.  Furthermore,  ubc4Aubc5A cells  are  also  par- 
tially defective for the rapid turnover of the a-factor ex- 
porter protein Ste6p (KoUing and Hollenberg, 1994) and 
for the endocytic uptake of a-factor (Hicke and Riezman, 
1996). ubc mutants that were found to have no effect on 
Ste3p turnover include the ubc4A ubc6A double mutant as 
well as ubc3(cdc34). Analysis of the endocytic uptake of 
a-factor also showed, in addition to UBC4 and UBC5, a 
partial requirement for  UBC1, while no effect of ubc2, 
ubc6, ubc7, or  ubc8 mutations was  evident (Hicke  and 
Riezman, 1996). 
Three E3 activities have so far been identified: the E3 
for the N-end rule pathway (encoded by UBR1) (Bartel et 
al., 1990), as well as two genes showing strong homology to 
the mammalian E3 activity, E6-AP, these being UFD4 and 
RSP5 (Johnson et al., 1995; Huibregtse et al., 1995). No ef- 
fect on Ste3p turnover was apparent in ubrlA cells (data 
not shown). As mentioned previously, RSP5 is now impli- 
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teins, the general amino acid permease and the uracil per- 
mease  (Hein  et  al.,  1995).  The  mammalian  E3,  E6-AP 
(Rsp5p homolog), normally acts together with an E2 that 
bears strongest homology to the yeast Ubc4p and Ubc5p 
(Scheffner  et  al.,  1994),  suggesting  that  Rsp5p,  together 
with the E2s Ubc4p  and Ubc5p, may act to regulate  the 
endocytosis of yeast cell surface proteins. We are investi- 
gating the participation of RSP5 in the ubiquitination and 
endocytosis of Ste3p. 
Level of Receptor Ubiquitination 
The ubiquitin-depletion  experiments  showed very strong 
effects on both receptor endocytosis and turnover, consis- 
tent with the entire cell surface receptor population being 
subject to a ubiquitin-dependent  uptake. Yet, analysis of 
receptor modification consistently showed only a small mi- 
nority of the receptors (~10%) with conjugated ubiquitin. 
This  level  of ubiquitination  is  consistent  with what has 
been observed  for other proteins  known to rapidly turn 
over by a ubiquitin-dependent proteosomal mechanism. In 
these cases, the highly ubiquitinated  species fail to accu- 
mulate, likely because of their rapid loss to proteosomal 
degradation. In the case of Ste3p, however, no obvious in- 
crease in the proportion of ubiquitinated receptor is seen 
even when turnover is blocked in pep4zl cells. One possi- 
bility is that ubiquitin's participation in endocytosis is tran- 
sient. Although  ubiquitin may mark surface receptor for 
uptake,  once uptake  is initiated, perhaps ubiquitin is re- 
moved. Indeed, it is well documented that not only is ubiq- 
uitin continuously added to substrate proteins by E2 and 
E3 enzymes, but it is also subject to continuous removal by 
isopeptidase activities (Finley and Chau, 1991). In endocy- 
tosis, such isopeptidase activities may operate at a down- 
stream transport step to remove ubiquitin moieties once 
endocytosis  is initiated.  Alternatively,  receptor ubiquitin 
levels may be low for artifactual reasons. While ubiquitin 
addition  is  ATP  dependent,  removal  is  not.  Therefore, 
some loss of ubiquitin modification could attend the prep- 
aration of protein extracts from whole cells. 
A number of cell surface proteins have now been shown 
to undergo ubiquitination. The functional role of this mod- 
ification has remained  uncertain.  Data  presented  in this 
paper  suggest  a  likely role for ubiquitination  in the  en- 
docytosis and turnover of the a-factor receptor. It will be 
interesting to see how generalized  these  findings will be 
for the metabolism of surface proteins in yeast and mam- 
malian cells. Is this a feature of all receptor-mediated en- 
docytosis,  a  feature  only  of vacuole-directed  (lysosome- 
directed) endocytic transport, or a feature of a specialized 
mode  of  endocytosis,  perhaps  a  clathrin-independent 
mechanism? 
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